SYNCOMFSyncom Formulations (India) Ltd.

    Syncom Formulations (India) Ltd: results and news

    Every Syncom Formulations (India) Ltd filing with the NSE and BSE that Blacklitt has written about, explained in plain words and linked to the filing, newest first: earnings.

    1 article · Pharmaceuticals · Latest 13 Nov 2026

    Two clear glass laboratory test tubes lying on a plain grey surface, one with a few dark specks on it.

    SYNCOMFSyncom Formulations (India) Ltd.

    Syncom Formulations (India) Q2 FY27 Results: Consolidated Net Profit ₹26.65 Crore on Total Income of ₹148 Crore

    Syncom Formulations (India) reported consolidated total income of ₹148.21 crore and net profit of ₹26.65 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹142.70 crore and net profit of ₹25.40 crore. The results were approved by the board on 13 Nov 2026, the company said in a filing on 13 Nov 2026.

    • Earnings
    • Pharmaceuticals

    Blacklitt Research3 min read